
Minimizing Risks with Stellate Ganglion Blocks
- Registration Closed
Myth: Stellate ganglion blocks (SGB) pose minimal risk when performed blind, using a landmark-based approach without imaging guidance.
Each participant will read the FactFinder and will answer post-test questions to earn continuing medical education (CME) credits.
Authors
Mathew Saffarian, DO, Ryan Mattie, MD, and Clark C. Smith, MD, MPH on behalf of the Spine Intervention Society’s Patient Safety Committee
Copyright
Materials presented in this activity have been made available by the Spine Intervention Society for educational purposes only. We reserve all rights to such material.
Educational Objectives
Upon completion of this activity, participants should be able to:
- Identify best practices to ensure patient safety during interventional spine procedures
- Cite the evidentiary basis for risk mitigation strategies in the safe performance of interventional pain procedures
Author Disclosures Information
RELEVANT FINANCIAL RELATIONSHIPS WITH ACCME-DEFINED COMMERCIAL INTERESTS
Mathew Saffarian, DO
Nothing to disclose
Ryan Mattie, MD
Nothing to disclose
Clark C. Smith, MD, MPH
Nothing to disclose
OTHER DISCLOSURES
Mathew Saffarian, DO
Advisory committees or review panels: American Medical Society for Sports Medicine, Michigan State University Committee
Grant and research support: Small 2500 Big Ten Grant for an epidemiology of concussion study
Ryan Mattie, MD
Travel Expenses: Course training for Vertiflex, Medtronic, Vertos
Clark C. Smith, MD, MPH
Nothing to disclose
References
References are provided within the FactFinder.
Accreditation Statement
The Spine Intervention Society (SIS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
Credit Designation Statement
SIS designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Date of Activity Release: 10/07/2020
Date of Activity Expiration: 10/06/2023